IP Verse

Lonza Biologics competitive analysis

Loading summary...

Latest patents of Lonza Biologics opposed by its competitors

Explore Lonza Biologics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP1915394
Jan 27, 2021High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell6
EP2467400
Jan 24, 2018Variant Immunoglobulins With Improved Manufacturability2

Latest publications and patents of Lonza Biologics New

Explore the latest publications and patents granted to Lonza Biologics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Lonza Biologics

EP1915394
Jan 27, 2021High-Level Expression Of Recombinant Antibody In A Mammalian Host CellRevoked
EP2467400
Jan 24, 2018Variant Immunoglobulins With Improved ManufacturabilityRevoked

Latest PTAB cases involving Lonza Biologics

Discover the latest PTAB cases involving Lonza Biologics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lonza Biologics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LONZA BIOLOGICS - 8 - -
EUROPEAN OPPOSITIONS30 - - -
LASAR2 - - -
MAIWALD136 - - -